Bridges v. Metabolife International, Inc.

119 F. App'x 660
CourtCourt of Appeals for the Fifth Circuit
DecidedJanuary 11, 2005
Docket04-20110
StatusUnpublished
Cited by6 cases

This text of 119 F. App'x 660 (Bridges v. Metabolife International, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fifth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Bridges v. Metabolife International, Inc., 119 F. App'x 660 (5th Cir. 2005).

Opinion

CARL E. STEWART, Circuit Judge: *

This is an appeal from the district court’s dismissal of Jeffrey Bridges’s (Bridges) personal injury claim against Metabolite International, Inc (Metabolite). Bridges maintains that he was injured as a result of ingesting Metabolite’s dietary supplement and that Metabolite fraudulently concealed its knowledge of the potential harm caused by its product. Bridges challenges the district court dismissal of his claim, with prejudice, as untimely. Finding no error on the part of the district court, we AFFIRM.

FACTUAL AND PROCEDURAL BACKGROUND

Jeffrey Bridges ingested Metabolite 356 for several months prior to September 14, 1999. Metabolite 356 is a dietary supplement containing ephedra and caffeine marketed by Metabolite International, Inc. On September 14, 1999, Bridges was transported to the emergency room of Conroe Regional Medical Center, and later transferred to Memorial Hermann Hospital. In response to general intake questions, Bridges advised medical personnel at both hospitals that he was taking Metabolite 356 in addition to his other medications. Doctors eventually diagnosed Bridges as having suffered a posterior hemispheric intracerebral hemorrhage of the lobar variety, i.e. a stroke. The doctors attributed Bridges’ stroke to hypertension and he was discharged. Bridges conducted no further investigation into the cause of his stroke.

Bridges argues he did not become aware of a possible connection between his stroke and Metabolite 356 until 2002, when he learned via media reports that dietary supplements containing ephedra and caffeine were linked to strokes. Upon learning that Metabolite 356 might have contributed to his stroke, Bridges contacted counsel and after an investigation, filed this personal injury suit on May 28, 2003. Metabolite responded with a general denial and *662 a motion for summary judgment based on the two year limitations period for filing personal injury actions. The district court dismissed Bridges’s suit as time barred. Bridges timely appealed.

STANDARD OF REVIEW

We review a district court’s grant of summary judgment de novo, applying the same standards as the district court. Evans v. City of Houston, 246 F.3d 344, 347 (5th Cir.2001). Summary judgment is appropriate “if the pleadings, depositions, answers to interrogatories, and admissions on file, together with the affidavits, if any, show that there is no genuine issue as to any material fact and that the moving party is entitled to judgment as a matter of law.” Fed.R.Civ.P. 56(c); see also Celotex Corp. v. Catrett, 477 U.S. 317, 322-23, 106 S.Ct. 2548, 91 L.Ed.2d 265 (1986). If the moving party meets the initial burden of showing there is no genuine issue of material fact, the burden shifts to the nonmoving party to produce evidence or designate specific facts showing the existence of a genuine issue for trial. Allen v. Rapides Parish Sch. Bd., 204 F.3d 619, 621 (5th Cir.2000) (internal quotation marks and citations omitted). Doubts are to be resolved in favor of the nonmoving party, and any reasonable inferences are to be drawn in favor of that party. See Burch v. City of Nacogdoches, 174 F.3d 615, 619 (5th Cir.1999).

DISCUSSION

The parties do not dispute that this case arises under Texas law and is therefore subject to the Texas statute of limitations for personal injury actions. Under Texas law, a personal injury action must be filed within two years after the cause of action accrues. Tex. Crv. Prac. & Rem.Code Ajnn. § 16.003(a). Bridges filed suit almost four years after the occurrence of the physical injury that is the impetus to this claim. In Texas, generally “a cause of action accrues and the two-year limitations period begins to run as soon as the owner suffers some injury, regardless of when the injury becomes discoverable.” Computer Assoc. Int'l, Inc. v. Altai Inc., 918 S.W.2d 453, 458 (Tex.1996). Statute of limitations can be tolled in certain circumstances. Bridges argues that summary judgment based on untimeliness is inappropriate in this case because (1) the defendant fraudulently concealed the cause of action, and (2) he was unable to discover his cause of action until a possible link between his stroke and Metabolite 356 become public in 2002.

Metabolite counters that Bridges is precluded from asserting the fraudulent concealment defense because Metabolite did not have actual knowledge of Bridges’s injury, and Metabolite did not have a duty to disclose a possible wrong because there was no fiduciary relationship. Metabolite also argues that Bridges cannot claim that his injury was inherently undiscoverable because Bridges knew of the cause of action, i.e., his stroke, and a reasonable person would have made an inquiry into the cause of their stroke.

A. Fraudulent Concealment

Under Texas law, fraudulent concealment is an equitable doctrine that tolls the statute of limitations. A defendant who has a duty to make a disclosure cannot avoid liability by concealing wrongdoing until the statute of limitations has run. Borderlon v. Peck, 661 S.W.2d 907, 908 (Tex.1983). Fraudulent concealment’s estoppel effect “ends when a party learns of facts, conditions, or circumstances which would cause a reasonably prudent person to make inquiry, which, if pursued, would lead to discovery of the concealed cause of action. Knowledge of such facts is in law equivalent to knowledge of the cause of action.” Casey v. Methodist Hosp., 907 *663 S.W.2d 898, 904 (Tex.App.1995). To show entitlement to the estoppel effect, the plaintiff must show: (1) the defendant had actual knowledge of the wrong, (2) a duty to disclose the wrong, and (3) a fixed purpose to conceal the wrong. Id. at 903 (quotation marks omitted). Mere concealment is insufficient to establish fraudulent concealment, the defendant must have had a duty to disclose. Seibert v. Gen. Motors Corp., 853 S.W.2d 773, 778 (Tex.App.1993). In the absence of an agreement, a duty to disclose arises when there is a confidential or fiduciary relationship. Trs. of Northwest Laundry and Dry Cleaners Health & Welfare Trust Fund v. Burzynski, 27 F.3d 153, 157 (5th Cir.1994). The party asserting the fraudulent concealment defense bears the burden of showing that the defendant was under a duty to make a disclosure. Nichols v. Smith,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Motorola Solutions, Inc. v. Hytera Commc'ns Corp.
314 F. Supp. 3d 931 (E.D. Illinois, 2018)
T. Agenbroad v. J. McEntire
595 F. App'x 383 (Fifth Circuit, 2014)
Hudson v. Remington Arms Co.
131 F. App'x 449 (Fifth Circuit, 2005)

Cite This Page — Counsel Stack

Bluebook (online)
119 F. App'x 660, Counsel Stack Legal Research, https://law.counselstack.com/opinion/bridges-v-metabolife-international-inc-ca5-2005.